ML22342B162
| ML22342B162 | |
| Person / Time | |
|---|---|
| Issue date: | 12/08/2022 |
| From: | Brooke Clark NRC/SECY |
| To: | Dan Dorman NRC/EDO |
| References | |
| SRM-M221206 | |
| Download: ML22342B162 (1) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 December 8, 2022 IN RESPONSE, PLEASE REFER TO: M221206 MEMORANDUM TO: Daniel H. Dorman Executive Director for Operations Digitally signed by Brooke P.
FROM: Brooke P. Clark, Secretary Brooke P. Clark Clark Date: 2022.12.08 13:54:43 -05'00'
SUBJECT:
STAFF REQUIREMENTS - MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES On December 6, 2022, the Commission was briefed on a variety of medical-related topics of regulatory interest by the following members of the Advisory Committee on the Medical Uses of Isotopes (ACMUI): Dr. Darlene Metter, ACMUI Chair and Diagnostic Radiologist; Dr. Michael OHara, Food and Drug Administration Representative; Dr. Hossein Jadvar, Nuclear Medicine Physician; and Megan Shober, Agreement State Representative. The topics discussed included an overview of ACMUI activities, ACMUIs review of Yttrium-90 medical events, emerging radiopharmaceuticals in an expanding nuclear medicine arena, impacts of the American Board of Radiologys request to eliminate its NRC-recognized certifications, and ACMUIs comments on the NRC staffs regulatory basis for the rulemaking on emerging medical technologies and Rubidium-82 generators.
The meeting, which was held in the Commissioners Hearing Room, One White Flint North, Rockville, Maryland at 10:00 a.m. Eastern Time, was open to members of the public attending in person and via webcast.
The Commission identified no requirements for staff action.
cc: Chair Hanson Commissioner Baran Commissioner Wright Commissioner Caputo Commissioner Crowell OGC CFO OCA OIG OPA ODs, RAs, ACRS, ASLBP PDR